Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) dropped 3.4% on Monday . The company traded as low as GBX 1.80 and last traded at GBX 1.83. Approximately 6,536,470 shares traded hands during trading, an increase of 311% from the average session volume of 1,591,377 shares. The stock had previously closed at GBX 1.90.
Cizzle Biotechnology Stock Down 3.5%
The stock has a market capitalization of £7.17 million, a price-to-earnings ratio of -9.93 and a beta of 0.02. The firm has a 50-day moving average of GBX 2.51 and a two-hundred day moving average of GBX 2.20.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported GBX (0.17) earnings per share (EPS) for the quarter.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.png){kind=logo}
